
Results 1 - 20 of 67 in Codexis
Codexis' CEO Presents at 2013 UBS Global Healthcare Conference
This is Codexis, and stimulate some interest on. I am John Nicols, CEO of Codexis. Comment?
Codexis to Present at 2013 UBS Global Healthcare Conference
Codexis, Inc. , a developer of engineered enzymes for pharmaceutical, biofuel and chemical production, today announced that John Nicols, President and CEO of Codexis, will present a company overview at the 2013 UBS Global Healthcare Conference on Monday, May 20, 2013 at 3:00 p.m. ET in New York City. Comment?
Codexis Rating Lowered to Neutral at Zacks
They currently have a $2.50 target price on the stock. Shares of Codexis remained flat at $2.19 during during mid-day trading trading on Wednesday. Comment?
Codexis, Inc. Reports First Quarter 2013 Results
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! Codexis, Inc. Comment?
Codexis' CEO Discusses Q1 2013 Results - Earnings Call Transcript
Welcome to Codexis' First Quarter Earnings Conference Call. This call is being webcast live on the Investors section of Codexis' website at codexis.com. This call is the property of Codexis and any recording, reproduction or transmission of this call without expressed written consent of Codexis is strictly prohibited. Comment?
Codexis (CDXS) Announces Quarterly Results
Codexis issued its quarterly earnings data on Tuesday. The company reported EPS for the quarter, beating the Thomson Reuters consensus estimate of by $0.11, Analyst Ratings Network.com reports. Comment?
Codexis Reports First Quarter 2013 Results
w/Photo
Codexis, Inc. , a developer of engineered enzymes for pharmaceutical, biofuel and chemical production, today announced financial results for the first quarter ended March 31, 2013. Comment?
Biofuel pioneer now supports natural gas
w/Photo
Formerly chief executive officer of Codexis Inc., the first advanced biofuel technology company to trade on a U.S. exchange, Shaw now says it's impossible to economically turn crop waste, wood and plants like switchgrass into fuel. Comment?
Biofuel Pioneer Forsakes Renewables to Make Gas-Fed Fuel: Energy
... industry he helped pioneer and decided the future instead lies with natural gas. Formerly chief executive officer of Codexis Inc., the first advanced biofuel technology company to trade on a U.S. exchange, Shaw now says it's impossible to ... Comment?
Biofuel Pioneer Forsakes Renewables to Make Gas-Fed Fuel: Energy
... industry he helped pioneer and decided the future instead lies with natural gas. Formerly chief executive officer of Codexis Inc., the first advanced biofuel technology company to trade on a U.S. exchange, Shaw now says it's impossible to ... Comment?
Codexis, Inc. to Announce First Quarter 2013 Financial Results on May 7, 2013
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! Codexis, Inc. Comment?
Codexis to Announce First Quarter 2013 Financial Results on May 7, 2013
Codexis, Inc. , a developer of engineered enzymes for pharmaceutical, biofuel and chemical production, today announced it will host a live conference call and audio webcast on Tuesday, May 7, 2013 at 4:30 p.m. Eastern Time to discuss its first quarter 2013 financial results for the period ended March 31, 2013. Comment?
Brazil's GranBio Open US Operations
... for the company's continued global expansion in advanced biorefinery development. Ms. Estes joins GranBio from Codexis , a developer of engineered enzymes for pharmaceutical, biofuel and chemical production, where she most recently was Vice ... Comment?
Codexis, Inc. to Present at 2013 Biotechnology Industry Organization...
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! Codexis, Inc. Comment?
Codexis to Present at 2013 BIO International Convention
Codexis, Inc. , a developer of engineered enzymes for pharmaceutical, biofuel and chemical production, announced today that Gjalt Huisman, Ph.D., Vice President, Pharmaceutical R&D at Codexis, will present at the 2013 BIO International Convention in Chicago, IL, on Tuesday, April 23, 2013. Comment?
Codexis Now Covered by Analysts at Sidoti
The firm set a "neutral" rating on the stock. Codexis traded down 0.07% on Tuesday, hitting $2.0985. Codexis has a 1-year low of $2.00 and a 1-year high of $4.55. The stock's 50-day moving average is currently $2.29. The company's market cap is $79.8 million. Comment?
Investor Ideas Snapshot; NASDAQ Top Percentage Gainers;
... of $53.3 million in 2008. At the end of 2012, revenue totaled $72.7 million, up 10 percent from the previous year. Codexis Inc., ( NASDAQ:CDXS ) trading at $2.56 gained $0.25 or 10.82% on a volume of 128,677 shares. Codexis, Inc., a developer of ... Comment?
Investor Ideas Snapshot; NASDAQ Top Percentage Gainers;
... of $53.3 million in 2008. At the end of 2012, revenue totaled $72.7 million, up 10 percent from the previous year. Codexis Inc., ( NASDAQ:CDXS ) trading at $2.56 gained $0.25 or 10.82% on a volume of 128,677 shares. Codexis, Inc., a developer of ... Comment?
Codexis Announces Next Generation CodeXymeA Cellulase Enzymes with Leading Performance
w/Photo
Codexis, Inc. , a developer of engineered enzymes for pharmaceutical, biofuel and chemical production, announced today the launch of CodeXymeA 4 and CodeXymeA 4X cellulase enzyme packages for use in producing cellulosic sugar for production of biofuels and bio-based chemicals. Comment?
Codexis Inc. is a company based out of Redwood City, Calif., that specializes in green chemistry. Comment?